openPR Logo
Press release

Global Keratoprosthesis Market Forecast Covering Growth Inclinations & Development Strategies until 2028 / keratoprosthesis market include F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated

11-09-2018 11:22 AM CET | Health & Medicine

Press release from: Fact.MR

Global Keratoprosthesis Market Forecast Covering Growth

Keratoprosthesis is a surgical procedure which replaces a diseased cornea with an artificial cornea. Infection, tissue necrosis, chronic inflammation and glaucoma are some of the post-operative complications observed after Keratoprosthesis Market. Devices used in keratoprosthesis like keratoprosthetic comprises of a central optic held in a cylindrical frame.  Keratoprosthesis surgical procedure replaces the section of cornea along with being placed in the surrounding tissue. A variety of biologic materials are being considered for improving the prosthetic corneal implants. In January 1992, FDA approved Boston KPro for patients suffering with severe corneal opacity. Boston KPro is further segmented into Type I and Type II. Boston KPro Type I is used in eyes when blink mechanism, eyelids, and tear film are intact.  Boston KPro Type II is used with severe dry eyes.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=859

According to the Eye Bank Association of America, there were around 23,000 endothelial keratoplasty cases in the United States in 2012. To avoid blindness and restore the damaged eye corneal surgery is the most adopted choice.

Rising geriatric population coupled with increasing incidence of eye diseases worldwide is expected to be the prime factor driving the growth of global keratoprosthesis market. Around 10 million people in the world suffering from corneal blindness. Therefore, rising incidences of corneal blindness are the primary factor driving the growth of the global keratoprosthesis market. Moreover, rising incidences of trauma cases are increasing the chances of eye injury which will further contribute in driving the growth of keratoprosthesis market. However, lack of availability of human cornea donor is expected to hamper the growth of keratoprosthesis market. Furthermore, keratoprosthesis is a costly surgery and thus the adoption of keratoprosthesis is quite low in developing countries which is expected to deter the growth of global keratoprosthesis market over the forecast period. The cost of the Boston KPro rose from $3,000 to $5,000 in 2010. Factors responsible for increasing cost are larger research expenditures and rising regulatory costs. Reimbursement by Medicaid, Medicare and other insurers for keratoprosthesis surgery is largely available.

To know more about the Keratoprosthesis Market Visit the link- https://www.factmr.com/report/859/keratoprosthesis-market

The keratoprosthesis market is expected to grow exponentially over the forecast period due to increasing incidence of corneal infection. Increasing visual disability due to the cloudy cornea for working people has increased the demand for keratoprosthesis surgeries. Based on product types, the global keratoprosthesis market is segmented into Boston Keratoprosthesis, alphaCor, and others. Amongst them, Boston Keratoprosthesis is the most widely used treatment option for corneal disease.

Keratoprosthesis Market: Regional Outlook

Geographically, global keratoprosthesis market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China and Japan, China, Japan, Middle East and Africa. North America is expected to dominate the keratoprosthesis market in terms of revenue share followed by Western Europe.  Asia Pacific is expected to experience delayed growth due to the lack of skilled physicians. However, Asia Pacific is expected to be the most lucrative market for keratoprosthesis with maximum CAGR due to growing penetration rate of keratoprosthesis surgeries in the emerging markets. Moreover, increasing number of healthcare practitioners and continuous improvements in the healthcare infrastructure is expected to enable robust industry growth in APAC region. The Middle East and Africa are expected to witness slow and significant growth over the forecast period. 

Keratoprosthesis Market: Key Players

Some of the players identified in global keratoprosthesis market include F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Argentina, Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan and China (India, Australia & New Zealand)
China
Japan
Middle East and Africa (GCC, South Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=859

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Keratoprosthesis Market Forecast Covering Growth Inclinations & Development Strategies until 2028 / keratoprosthesis market include F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated here

News-ID: 1358522 • Views:

More Releases from Fact.MR

Surgical Gown Market to Reach US$ 2,734.7 Million by 2034 with 5.4% CAGR
05-06-2024 | Health & Medicine
Fact.MR
Surgical Gown Market to Reach US$ 2,734.7 Million by 2034 with 5.4% CAGR
The surgical gown market (手術用ガウン市場) is projected to reach a value of US$ 1,614.3 million in 2024 and is anticipated to grow to US$ 2,734.7 million by 2034, with a compound annual growth rate (CAGR) of 5.4% from 2024 to 2034. The growth in sales of surgical gowns is driven by the rising number of surgical procedures in the medical and healthcare sectors. Surgical gowns are essential protective apparel worn
Rapid Expansion Expected in Tracheal Stents Market, Projected to Reach US$ 272 Million by 2033 with 8% CAGR
05-06-2024 | Health & Medicine
Fact.MR
Rapid Expansion Expected in Tracheal Stents Market, Projected to Reach US$ 272 M …
The global tracheal stents market (気管ステント市場), valued at US$ 126 million in 2023, is anticipated to surge to US$ 272 million by 2033. Tracheal stents, utilized to stabilize surgical reconstructions of the larynx or trachea and prevent lumen collapse, are known as laryngeal and tracheal stents. These stents are crucial post-surgery, especially after anterior or posterior splitting of the cricoid plate, with or without cartilage implantation, aiding in maintaining structural
Infant Nutritional Premix Market Forecasted to Achieve US$ 438.6 Million by 2033, with 6.1% CAGR
05-06-2024 | Food & Beverage
Fact.MR
Infant Nutritional Premix Market Forecasted to Achieve US$ 438.6 Million by 2033 …
According to Fact.MR, the global infant nutritional premixes market is expected to reach US$ 438.6 million by 2033, from its current value of US$ 242.6 million in 2023. Infant nutritional premix sales are expected to grow globally at a compound annual growth rate (CAGR) of 6.1% between 2023 and 2033. The goal of infant nutritional premixes, also referred to as customized nutritional blends, is to raise the total nutrient content of
Vegetable Oils Market Anticipates US$ 336 Billion Valuation by 2032, Driven by 4.6% CAGR
05-06-2024 | Food & Beverage
Fact.MR
Vegetable Oils Market Anticipates US$ 336 Billion Valuation by 2032, Driven by 4 …
The vegetable oils market is expected to grow at a compound annual growth rate (CAGR) of 4.6% through 2032, from its current valuation of US$ 214 billion in 2022 to US$ 336 billion by the end of 2032. The mechanical extraction procedure, along with several other extraction methods including solvent extraction and hydrogenation deodorization, are seeing a surge in growth prospects due to their industrial applications. Manufacturers can expand their production

All 5 Releases


More Releases for Keratoprosthesis

01-07-2022 | Health & Medicine
Fact.MR
Keratoprosthesis Market: Major Companies, Industry Analysis, Application, Region …
The New Report "Keratoprosthesis Market" published by Fact.MR, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis that is very detailed have been included in the report of the Keratoprosthesis market for the analysis period of 2021 – 2031. Get In-depth Insights Request for Sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=859 Through the new research
08-03-2021 | Health & Medicine
Fact.MR
Keratoprosthesis Market to Witness Increase in Revenues during 2021-2031 | F. …
The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Keratoprosthesis. Keratoprosthesis market study depicts an in-depth analysis on the current status of Keratoprosthesis market that consists of important types, and end uses. To Get In-depth Information View the Report - https://www.factmr.com/report/859/keratoprosthesis-market Exponential rise in the use of medical devices on account of continued advances in design and superior operative care
07-14-2021 | Health & Medicine
Fact.MR
Keratoprosthesis Market Global Upcoming Demand, Growth Analysis and Forecast til …
The market report envelopes an all-in information of the global Keratoprosthesis market and the nature of the market growth over the foreseeable period. Keratoprosthesis Market to grow significantly during the years, 2021-2031. Amongst the product types, Boston Keratoprosthesis is the most widely used treatment. To Get In-depth Information View the Report - https://www.factmr.com/report/859/keratoprosthesis-market Rising geriatric population coupled with increasing incidence of eye diseases worldwide is expected to be the prime factor driving the
Keratoprosthesis Market by Key Players - F. Hoffmann-La Roche Ltd., Regeneron Ph …
Keratoprosthesis Market: Insights Exponential rise in the use of medical devices on account of continued advances in design and superior operative care has led to increase in the use of artificial cornea or keratoprosthesis in the recent years. The keratoprosthesis is intended to replace the damaged corneal tissue and restore vision of the patients with bilateral corneal disease. Corneal transplantation is one of the common treatment to correct several corneal opacity
Keratoprosthesis Market by Key Players - F. Hoffmann-La Roche Ltd., Regeneron Ph …
Keratoprosthesis Market: Insights Exponential rise in the use of medical devices on account of continued advances in design and superior operative care has led to increase in the use of artificial cornea or keratoprosthesis in the recent years. The keratoprosthesis is intended to replace the damaged corneal tissue and restore vision of the patients with bilateral corneal disease. Corneal transplantation is one of the common treatment to correct several corneal opacity
Keratoprosthesis Market Shares, Strategies and Forecast Worldwide, 2018 to 2028( …
Exponential rise in the use of medical devices on account of continued advances in design and superior operative care has led to increase in the use of artificial cornea or keratoprosthesis in the recent years. The keratoprosthesis is intended to replace the damaged corneal tissue and restore vision of the patients with bilateral corneal disease. Corneal transplantation is one of the common treatment to correct several corneal opacity which involves